A quarter of adults in the UK are clinically obese and therefore at an increased risk of developing chronic diseases. NHS advice is to eat fewer calories and take more exercise to lose weight. Increasingly, drug treatments and surgery are being considered as a means to lose weight for extremely obese people who have had difficulty in adhering to lifestyle changes. This briefing discusses the current methods used to manage and treat obesity.
Obesity Treatments (358 KB, PDF)
Try entering your details into this BMI calculator from the BBC and see where you stand in your country.
Obesity Treatments (358 KB, PDF)
On December 31, 2020 the four UK Chief Medical Officers (CMOs) published a statement announcing changes to the dosing schedule for the second dose of the Pfizer/BioNTech and University of Oxford/AstraZeneca vaccines. It stated that the interval between the first and second dose should be extended from 3–4 weeks to up to 12 weeks. This rapid response examines the evidence behind this decision.
The body of research investigating the effects of Coronavirus infection on pregnancy is growing. What is the available evidence? How does COVID-19 affect pregnant women and their babies? Is the virus transmitted between mothers and babies? Are some women and babies at greater risk than others?
COVID-19 vaccine roll-out started in the UK on 8 December 2020. Results from Phase 3 clinical trials have been published for all the vaccines approved for use in the UK. But how does the performance of vaccines under real world conditions differ from clinical trial results? When will we able to observe the impacts of the COVID-19 vaccination programme?
